FIGURE 8.

Plasma glucose (a) and insulin (b) measurements, and (c) HOMA‐IR for each treatment. The corticosterone group illustrated significantly (p ≤ 0.05) elevated insulin concentrations and insulin resistance (HOMA‐IR) compared to all other treatment groups. (a) represents significantly (p ≤ 0.05) different than the naïve control group, (b) represents significantly (p ≤ 0.05) different from the vehicle control group, (c) represents significantly (p ≤ 0.05) different from the mirabegron low treatment, and (d) represents significantly (p ≤ 0.05) different from the mirabegron high treatment